The interest in new bone substitutes is rapidly increasing in the field of orthopedic surgery. A variety of calcium phosphate bone cement has been developed and different additives have been used to improve their biocompatibility and bioactivity. Following a biomimetic strategy aimed at reproducing bone characteristics, this study investigates the biological properties of a new gelatin enriched calcium phosphate cement (GEL-CP) that exhibits improved mechanical properties with respect to cement prepared without gelatin (C-CP).
Human osteoblast MG63 were cultured on the surfaces of GEL-CP and were compared to cells cultured on C-CP samples, and on polystyrene of plate culture as control (C). Cell attachment, proliferation and differentiation were evaluated up to 21 days. SEM revealed that osteoblasts grown on GEL-CP showed a normal morphology and biological tests demonstrated very good rate of proliferation and viability in every experimental time. The presence of gelatin stimulated alkaline phosphatase activity, collagen and transforming growth factor ß1 production. The data indicate that the new cement GEL-CP favors osteoblast proliferation, activation of their metabolism and differentiation. The remarkable improvement of the setting properties of the calcium phosphate cement due to the presence of gelatin suggest that the biomimetic composite material could be successfully applied as bone substitute.
BonherM.. Calcium orthophosphates in medicine: From ceramics to calcium phosphate cements.Injury2000; 31: D37–47.
2.
FernándezE., GilF.J., GinebraM.P., DriessensF.C.M., PlanellJ.A., BestS.M.. Calcium phosphate bone cements for clinical applications. Part II: Precipitate formation during setting reactions.J Mater Sci Mater Med1999; 10: 177–83.
3.
KhairounI., MagneD., GauthierO., BoulerJ.M., AguadoE., DaculsiG., WeissP.. In vitro characterization and in vivo properties of a carbonated apatite bone cement.J Biomed Mater Res2002; 60: 633–42.
4.
GbureckU., GrolmsO., BarraletJ.E., GroverL.M., ThullR.. Mechanical activation and cement formation of beta-tricalcium phosphate.Biomaterials2003; 24: 4123–31.
5.
DriessensF.C.M., BoltongM.C., de MaeyerE.A.P., WenzR., NiesB., PlanellJ.A.. The Ca/P range of nanoapatitic calcium phosphate cements.Biomaterials2002; 23: 4011–7.
6.
DriessensF.C.M., BoltongM.G., De MaeyerE.A.P., VerbeeckR.M.H., WenzR.. Effect of temperature and immersion on the setting of some calcium phosphate cements.J Mater Sci Mater Med2000; 11: 453–7.
7.
KhairounI., DriessensF.C.M., BoltongM.G., PlanellJ.A.. Addition of cohesion promotors to calcium phosphate cements.Biomaterials1999; 20: 393–8.
8.
Dos SantosL.A., De OliveiraL.C., RigoE.C.S., CarrodeguasR.G., BoschiA.O., DeArrudaA.C.F.. Influence of polymeric additives on the mechanical properties of α-tricalcium phosphate cement.Bone1999; 25: 99–102.
9.
DurucanC., BrownP.W.. Low temperature formation of calcium-deficient hydroxyapatite-PLA/PLGA composites.J Biomed Mater Res2000; 51: 717–25.
10.
MickiewiczR.A., MayesA.M., KnaackD.. Polymer-calcium phosphate cement composites for bone substitutes.J Biomed Mater Res2002; 61: 581–92.
11.
SardaS., FernándezE., NilssonM., BalcellsM., PlanellJ.A.. Kinetic study of citric acid influence on calcium phosphate bone cements as water-reducing agent.J Biomed Mater Res2002; 61: 653–9.
12.
BigiA., BracciB., PanzavoltaS.. Effect of added gelatin on the properties of calcium phosphate cement.Biomaterials2004; 25: 2893–9.
BigiA., BoaniniE., BotterR., PanzavoltaS., RubiniK.. α-tricalcium phosphate hydrolysis to octacalcium phosphate: Effect of sodium polyacrylate.Biomaterials2002; 23: 1849–54.
15.
DurucanC., BrownP.W.. Reactivity of alpha-tricalcium phosphate.J Mater Sci2002; 37: 963–9.
16.
OtaniY., TabataY., IkadaY.. Hemostatic capability of rapidly curable glues from gelatin poly(L-glutamic acid) and carbodiimide.Biomaterials1998; 19: 2091–8.
17.
RoseP.J., MarkH.F., BikalesN.M., OverbergerC.G., MengesG., KroschwitzJ.I.. Encyclopedia of Polymer Science and Engineering, 2nd ed., Vol. 7. New York: Wiley Interscience, 1987.
18.
DigenisG.A., GoldT.B., ShahV.P.. Cross-linking of gelatin capsules and its relevance to their in vitro - in vivo performance.J Pharmaceutical Sci1994; 83: 915–21.
19.
BigiA., PanzavoltaS., RubiniK.. Setting mechanism of a biomimetic bone cement.Chem Mater2004 (in press).
20.
FernándezE., GilF.J., BestS.M., GinebraM.P., DriessensF.C.M., PlanellJ.A.. Improvement of the mechanical properties of new calcium phosphate bone cements in the CaHPO4-Ca3(PO4)2 system: Compressive strength and microstructural development.J Biomed Mater Res1998; 41: 560–7.
AubinJ.E., LiuF., MalavalL., GuptaA.K.. Osteoblast and chondroblast differentiation.Bone1995; 17(Suppl): S77–83.
23.
MalavalL., LiuF., RocheP., AubinJ.E.. Kinetics of osteo-progenitor proliferation and osteoblast differentiation in vitro.J Cell Biochem1999; 74: 616–27.
24.
AtsushiE., KorenoriO., SatoshiI., ShigeyukiE., TakayoshiN., YukichiU.. Effects of α-TCP and TetCP on MC3T3-E1 proliferation, differentiation and mineralization.Biomaterials2003; 24: 831–6.
25.
FranceschiR.T., IyerB.S.. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells.J Bone Miner Res1992; 7: 235–46.
26.
CowlesE.A., DeRomeD., PastizzoG., BraileyL.L., GronowiczG.A.. Mineralization and the expression of matrix proteins during in vivo bone development.Calcif Tissue Int1998; 62: 74–82.
27.
FiniM., GiardinoR., BorsariV., TorricelliP., RimondiniL., GiavaresiG., Nicoli AldiniN.. In vitro behaviour of osteoblasts cultured on orthopaedic biomaterials with different surface roughness, uncoated and fluorohydroxyapatite-coated, relative to the in vivo osteointegration rate.Int J Artif Organs2003; 26: 520–8.
28.
Mayr-WohlfartU., FiedlerJ, GuntherK.P., PuhlW., KesslerS.. Proliferation and differentiation rates of a human osteoblast-like cell line (SaOS-2) in contact with different bone substitute materials.J Biomed Mater Res2001; 57: 132–9.
29.
HarrisS.E., BonewaldL.F., HarrisM.A., SabatiniM., DallasS., FengJ.Q., Ghosh-ChoudhuryN., WozneyJ., MundyG.R.. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in longterm cultures of fetal rat calvarial osteoblasts.J Bone Miner Res1994; 9: 855–63.
30.
ZhangaH., AhmadcM., GronowiczaG.. Effects of transforming growth factor-beta 1 (TGF-ß1) on in vitro mineralization of human osteoblasts on implant materials.Biomaterials2003; 24: 2013–20.
31.
Al SaffarN., RevellP.A., KhwajaH.A., BonfieldW.. Assessment of the role of cytokines in bone resorption in patients with total joint replacement.J Mater Sci Mater Med1995; 6: 762–7.
32.
TorricelliP., FiniM., BorsariV., LengerH., BernauerJ., TschonM., BonazziV., GiardinoR.. Biomaterials in orthopedic surgery: Effects of a nickel-reduced stainless steel on in vitro proliferation and activation of human osteoblasts.Int J Artif Organs2003; 26: 952–7.
